Clinical Trial Update: Tislelizumab Combined With sCRT in Stage IIIB/C-IV Non-Squamous Non-Small Cell Lung Cancer：A Prospective, Single-Arm, Phase II Study [Phase 2]

View source ↗

Summary

This document updates an ongoing, single-arm Phase II trial evaluating tislelizumab with sCRT (short-course chemoradiotherapy) in stage IIIB/C-IV non-squamous n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Tislelizumab (tislelizumab)

Snippet

Sponsor: Zibo Municipal Hospital | Conditions: NSCLC, Tislelizumab | Phase 2 | Status: RECRUITING